Lidocaine patch (5%) produces a selective, but incomplete block of Ad and C fibers

被引:77
作者
Krumova, Elena K. [1 ]
Zeller, Martina [1 ]
Westermann, Andrea [1 ]
Maier, Christoph [1 ]
机构
[1] Univ Bochum, Dept Pain Management, BG Univ Hosp Bergmannsheil GmbH, D-44789 Bochum, Germany
关键词
Neuropathic pain; Quantitative sensory testing; Lidocaine patch (5%); Mechanism-based treatment; Small-fiber block; LIGNOCAINE MEDICATED PLASTER; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; TOPICAL LIDOCAINE; DOUBLE-BLIND; OPEN-LABEL; PHARMACOLOGICAL-TREATMENT; DIABETIC POLYNEUROPATHY; NERVE BLOCK; LONG-TERM;
D O I
10.1016/j.pain.2011.08.020
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Topical lidocaine (5%) leads to sufficient pain relief in only 29%-80% of treated patients, presumably by small-fiber block. The reasons for nonresponse are unclear; it may be due to different underlying pain mechanisms or partly insufficient anesthetic effect. Using quantitative sensory testing (QST) following the protocol of the DFNS (German Research Network on Neuropathic Pain), this study aims to assess the type and extent of somatosensory changes after lidocaine application in healthy volunteers. Twenty-six healthy volunteers underwent QST on the volar forearm, including thermal and mechanical detection and pain thresholds, twice before (for baseline retest reliability) and once after 6-hour simultaneous application with lidocaine patch 5% and contralateral placebo in a double-blinded manner. Pre and post differences of QST parameters were analyzed by paired t-test (Bonferroni-corrected alpha 0.0023). QST profiles did not change between the 2 baseline measurements and after the placebo application. Lidocaine application led to a significant change of only the small-fiber-associated thresholds (increase of thermal detection and mechanical pain thresholds, decrease of mechanical pain sensitivity). Tactile detection thresholds representing Ab function remained unchanged. Interindividually, the extent of the small-fiber block varied widely (eg, thermal detection thresholds: in 54% of the subjects there were only minimal changes; in only 8% were there changes of > 60% of the maximal achievable value). Topical lidocaine (5%) induces thermal hypoesthesia and pinprick hypoalgesia, suggesting an isolated but only partial block of Ad and C fibers of unpredictable extent. Further studies must analyze the influencing factors and determine whether patients with poor analgesic effect, in particular, are those with insufficient small-fiber block. (C) 2011 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 40 条
[1]   Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale [J].
Argoff, CE ;
Galer, BS ;
Jensen, MP ;
Oleka, N ;
Gammaitoni, AR .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 :S21-S28
[2]   Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA®) cream on spontaneous and evoked pain in post-herpetic neuralgia [J].
Attal, N ;
Brasseur, L ;
Chauvin, M ;
Bouhassira, D .
PAIN, 1999, 81 (1-2) :203-209
[3]   EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision [J].
Attal, N. ;
Cruccu, G. ;
Baron, R. ;
Haanpaa, M. ;
Hansson, P. ;
Jensen, T. S. ;
Nurmikko, T. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) :1113-E88
[4]   Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy [J].
Barbano, RL ;
Herrmann, DN ;
Hart-Gouleau, S ;
Pennella-Vaughan, J ;
Lodewick, PA ;
Dworkin, RH .
ARCHIVES OF NEUROLOGY, 2004, 61 (06) :914-918
[5]   Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy Interim Analysis from an Open-Label, Two-Stage Adaptive, Randomized, Controlled Trial [J].
Baron, Ralf ;
Mayoral, Victor ;
Leijon, Goran ;
Binder, Andreas ;
Steigerwald, Ilona ;
Serpell, Michael .
CLINICAL DRUG INVESTIGATION, 2009, 29 (04) :231-241
[6]  
Binder A, 2011, PLOS ONE, V29
[7]   Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia Results of a Double-Blind, Placebo-Controlled, Multinational Efficacy and Safety Trial [J].
Binder, Andreas ;
Bruxelle, Jean ;
Rogers, Peter ;
Hans, Guy ;
Boesl, Irmgard ;
Baron, Ralf .
CLINICAL DRUG INVESTIGATION, 2009, 29 (06) :393-408
[8]   Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster [J].
Campbell, BJ ;
Rowbotham, M ;
Davies, PS ;
Jacob, P ;
Benowitz, NL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (05) :1343-1350
[9]   Topical lidocaine patch relieves a variety of neuropathic pain conditions: An open-label study [J].
Devers, A ;
Galer, BS .
CLINICAL JOURNAL OF PAIN, 2000, 16 (03) :205-208
[10]   Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update [J].
Dworkin, Robert H. ;
O'Connor, Alec B. ;
Audette, Joseph ;
Baron, Ralf ;
Gourlay, Geoffrey K. ;
Haanpaa, Maija L. ;
Kent, Joel L. ;
Krane, Elliot J. ;
LeBel, Alyssa A. ;
Levy, Robert M. ;
Mackey, Sean C. ;
Mayer, John ;
Miaskowski, Christine ;
Raja, Srinivasa N. ;
Rice, Andrew S. C. ;
Schmader, Kenneth E. ;
Stacey, Brett ;
Stanos, Steven ;
Treede, Rolf-Detlef ;
Turk, Dennis C. ;
Walco, Gary A. ;
Wells, Christopher D. .
MAYO CLINIC PROCEEDINGS, 2010, 85 (03) :S3-S14